BioCentury
ARTICLE | Clinical News

Enclomiphene citrate: Completed Phase II enrollment

February 22, 2016 8:00 AM UTC

Repros completed enrollment of >45 obese patients in the double-blind, placebo-controlled, U.S. Phase II ZA-205 trial evaluating 12.5 and 25 mg oral enclomiphene for 12 months in combination with diet...